CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...